Abstract
The present study has employed the technique of fast cyclic voltammetry to measure electrically-evoked dopamine release within the central amygdaloid complex in a rat brain slice. Local electrical stimulation caused the release of an electroactive substance which was identified, biochemically and pharmacologically, as being neuronal dopamine. Dopamine release could be inhibited by the dopamine D2 receptor agonist, quinpirole, but not by the D1 receptor agonist, SKF38393. Quinpirole-induced inhibitions were antagonized by sulpiride, metoclopramide and clozapine but not by SCH23390. It is concluded that dopamine release in the amygdala can be modulated by presynaptic D2 receptors which appear to be the same type as those found in striatum and nucleus accumbens.
MeSH terms
-
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
-
2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- / pharmacology
-
Amygdala / chemistry
-
Amygdala / drug effects
-
Amygdala / metabolism*
-
Animals
-
Antipsychotic Agents / pharmacology
-
Benzazepines / pharmacology
-
Clozapine / pharmacology*
-
Dopamine / metabolism*
-
Electric Stimulation
-
Ergolines / pharmacology
-
Male
-
Metoclopramide / pharmacology
-
Neurotransmitter Uptake Inhibitors / pharmacology
-
Nialamide / pharmacology
-
Piperazines / pharmacology
-
Quinpirole
-
Rats
-
Rats, Inbred Strains
-
Receptors, Dopamine / classification
-
Receptors, Dopamine / drug effects
-
Receptors, Dopamine / physiology*
-
Secretory Rate / drug effects
-
Sulpiride / pharmacology
Substances
-
Antipsychotic Agents
-
Benzazepines
-
Ergolines
-
Neurotransmitter Uptake Inhibitors
-
Piperazines
-
Receptors, Dopamine
-
Quinpirole
-
2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-
-
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
-
Sulpiride
-
vanoxerine
-
Clozapine
-
Metoclopramide
-
Nialamide
-
Dopamine